STOCK TITAN

[Form 4] Septerna, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Samira Shaikhly, identified as Chief People Officer of Septerna, Inc. (SEPN), acquired a derivative award disclosed on Form 4. The filing reports a grant of a stock option to purchase 30,000 shares of Septerna common stock with an exercise price of $11.70; the transaction date is 08/07/2025 and the Form 4 is signed on 08/11/2025.

The option is owned directly, the instrument lists an expiration date of 08/06/2035, and the grant vests in 1/48th of the shares monthly on each monthly anniversary of August 1, 2025, subject to continuous service. Following the transaction the reporting person beneficially owns 30,000 options.

Samira Shaikhly, identificata come Chief People Officer di Septerna, Inc. (SEPN), ha acquisito una provvigione derivata comunicata nel Modulo 4. Il deposito riporta l'assegnazione di una opzione su azioni per acquistare 30,000 azioni ordinarie di Septerna con un prezzo di esercizio di $11.70; la data della transazione è 08/07/2025 e il Modulo 4 è firmato il 08/11/2025.

L'opzione è posseduta direttamente, lo strumento indica una data di scadenza del 08/06/2035, e la concessione matura in 1/48 delle azioni ogni mese in occasione di ogni anniversario mensile del 1 agosto 2025, subordinata alla permanenza nel servizio. Dopo la transazione, la persona segnalante detiene beneficiariamente 30,000 opzioni.

Samira Shaikhly, identificada como Chief People Officer de Septerna, Inc. (SEPN), adquirió una remuneración derivada divulgada en el Formulario 4. La presentación informa la concesión de una opción sobre acciones para comprar 30,000 acciones ordinarias de Septerna con un precio de ejercicio de $11.70; la fecha de la transacción es 08/07/2025 y el Formulario 4 está firmado el 08/11/2025.

La opción es propiedad directa, el instrumento establece una fecha de vencimiento del 08/06/2035, y la concesión se consolida en 1/48 de las acciones cada mes en cada aniversario mensual del 1 de agosto de 2025, condicionada al servicio continuo. Tras la operación, la persona informante posee beneficiariamente 30,000 opciones.

Samira Shaikhly는 Septerna, Inc. (SEPN)의 Chief People Officer로 확인되며, Form 4에 보고된 파생 보상을 취득했습니다. 제출 서류에는 주식 매수선택권으로 Septerna 보통주 30,000주를 행사가격 $11.70에 매수할 수 있는 부여가 보고되어 있으며; 거래일은 08/07/2025, Form 4 서명일은 08/11/2025입니다.

해당 옵션은 직접 보유되고 있으며, 증서는 만료일을 08/06/2035으로 명시하고 있고, 부여는 2025년 8월 1일의 매월 기념일마다 매월 1/48씩 베스팅되며 지속적인 근무를 조건으로 합니다. 거래 후 보고인은 실질적으로 30,000개의 옵션을 보유합니다.

Samira Shaikhly, identifiée comme Chief People Officer de Septerna, Inc. (SEPN), a acquis une attribution dérivée divulgée sur le Formulaire 4. Le dépôt indique l'octroi d'une option sur actions permettant d'acheter 30,000 actions ordinaires de Septerna au prix d'exercice de $11.70 ; la date de la transaction est le 08/07/2025 et le Formulaire 4 est signé le 08/11/2025.

L'option est détenue directement, l'instrument précise une date d'expiration au 08/06/2035, et l'attribution devient acquise à hauteur de 1/48 des actions chaque mois à chaque anniversaire mensuel du 1er août 2025, sous réserve d'une présence continue. Après la transaction, la personne déclarante détient à titre bénéficiaire 30,000 options.

Samira Shaikhly, identifiziert als Chief People Officer von Septerna, Inc. (SEPN), erwarb eine derivative Vergütung, die in Formular 4 offengelegt wurde. Die Einreichung meldet die Gewährung einer Aktienoption zum Kauf von 30,000 Septerna-Stammaktien zu einem Ausübungspreis von $11.70; das Transaktionsdatum ist 08/07/2025 und das Formular 4 ist unterzeichnet am 08/11/2025.

Die Option wird direkt gehalten, das Instrument nennt ein Verfallsdatum am 08/06/2035, und die Zuteilung wird in monatlichen Raten von je 1/48 der Aktien an jedem monatlichen Jahrestag des 1. August 2025 fällig, vorbehaltlich fortlaufender Tätigkeit. Nach der Transaktion besitzt die meldepflichtige Person wirtschaftlich 30,000 Optionen.

Positive
  • Grant of 30,000 stock options reported, providing clear disclosure of executive compensation
  • Exercise price disclosed: $11.70 per share
  • Detailed vesting schedule: 1/48th monthly installments beginning Aug 1, 2025, is specified
  • Direct beneficial ownership: 30,000 options held directly following the transaction
Negative
  • None.

Insights

TL;DR: Routine officer equity grant—30,000 options at $11.70 strike, monthly vesting over 48 months, long exercise window to 2035.

The Form 4 documents a standard executive equity award rather than an open-market transaction. Key facts: 30,000 options, $11.70 exercise price, acquisition date 08/07/2025, direct ownership and expiration on 08/06/2035. The monthly 1/48th vesting schedule ties compensation to continued service; the long expiration is typical for option grants. This disclosure is material as a compensation and governance item but appears routine for executive awards.

TL;DR: Governance disclosure shows officer-level grant with time-based vesting; standard signature by attorney-in-fact on Form 4.

The filing identifies the reporting person as an officer (Chief People Officer) and shows the option grant reported via Form 4, signed by an attorney-in-fact (Ran Xiao) on 08/11/2025. The explicit vesting language—1/48th monthly installments beginning Aug 1, 2025—and direct ownership of 30,000 options are clear governance items for stakeholders monitoring executive compensation. No other governance actions or departures are disclosed.

Samira Shaikhly, identificata come Chief People Officer di Septerna, Inc. (SEPN), ha acquisito una provvigione derivata comunicata nel Modulo 4. Il deposito riporta l'assegnazione di una opzione su azioni per acquistare 30,000 azioni ordinarie di Septerna con un prezzo di esercizio di $11.70; la data della transazione è 08/07/2025 e il Modulo 4 è firmato il 08/11/2025.

L'opzione è posseduta direttamente, lo strumento indica una data di scadenza del 08/06/2035, e la concessione matura in 1/48 delle azioni ogni mese in occasione di ogni anniversario mensile del 1 agosto 2025, subordinata alla permanenza nel servizio. Dopo la transazione, la persona segnalante detiene beneficiariamente 30,000 opzioni.

Samira Shaikhly, identificada como Chief People Officer de Septerna, Inc. (SEPN), adquirió una remuneración derivada divulgada en el Formulario 4. La presentación informa la concesión de una opción sobre acciones para comprar 30,000 acciones ordinarias de Septerna con un precio de ejercicio de $11.70; la fecha de la transacción es 08/07/2025 y el Formulario 4 está firmado el 08/11/2025.

La opción es propiedad directa, el instrumento establece una fecha de vencimiento del 08/06/2035, y la concesión se consolida en 1/48 de las acciones cada mes en cada aniversario mensual del 1 de agosto de 2025, condicionada al servicio continuo. Tras la operación, la persona informante posee beneficiariamente 30,000 opciones.

Samira Shaikhly는 Septerna, Inc. (SEPN)의 Chief People Officer로 확인되며, Form 4에 보고된 파생 보상을 취득했습니다. 제출 서류에는 주식 매수선택권으로 Septerna 보통주 30,000주를 행사가격 $11.70에 매수할 수 있는 부여가 보고되어 있으며; 거래일은 08/07/2025, Form 4 서명일은 08/11/2025입니다.

해당 옵션은 직접 보유되고 있으며, 증서는 만료일을 08/06/2035으로 명시하고 있고, 부여는 2025년 8월 1일의 매월 기념일마다 매월 1/48씩 베스팅되며 지속적인 근무를 조건으로 합니다. 거래 후 보고인은 실질적으로 30,000개의 옵션을 보유합니다.

Samira Shaikhly, identifiée comme Chief People Officer de Septerna, Inc. (SEPN), a acquis une attribution dérivée divulgée sur le Formulaire 4. Le dépôt indique l'octroi d'une option sur actions permettant d'acheter 30,000 actions ordinaires de Septerna au prix d'exercice de $11.70 ; la date de la transaction est le 08/07/2025 et le Formulaire 4 est signé le 08/11/2025.

L'option est détenue directement, l'instrument précise une date d'expiration au 08/06/2035, et l'attribution devient acquise à hauteur de 1/48 des actions chaque mois à chaque anniversaire mensuel du 1er août 2025, sous réserve d'une présence continue. Après la transaction, la personne déclarante détient à titre bénéficiaire 30,000 options.

Samira Shaikhly, identifiziert als Chief People Officer von Septerna, Inc. (SEPN), erwarb eine derivative Vergütung, die in Formular 4 offengelegt wurde. Die Einreichung meldet die Gewährung einer Aktienoption zum Kauf von 30,000 Septerna-Stammaktien zu einem Ausübungspreis von $11.70; das Transaktionsdatum ist 08/07/2025 und das Formular 4 ist unterzeichnet am 08/11/2025.

Die Option wird direkt gehalten, das Instrument nennt ein Verfallsdatum am 08/06/2035, und die Zuteilung wird in monatlichen Raten von je 1/48 der Aktien an jedem monatlichen Jahrestag des 1. August 2025 fällig, vorbehaltlich fortlaufender Tätigkeit. Nach der Transaktion besitzt die meldepflichtige Person wirtschaftlich 30,000 Optionen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shaikhly Samira

(Last) (First) (Middle)
C/O SEPTERNA, INC.
250 EAST GRAND AVENUE

(Street)
SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Septerna, Inc. [ SEPN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief People Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $11.7 08/07/2025 A 30,000 (1) 08/06/2035 Common Stock 30,000 $0 30,000 D
Explanation of Responses:
1. 1/48th of the shares subject to such option shall vest and become exercisable in substantially equal monthly installments on each monthly anniversary of August 1, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date.
/s/ Ran Xiao, Attorney-in-Fact 08/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did SEPN insider Samira Shaikhly acquire on 08/07/2025?

She was granted a stock option to purchase 30,000 shares with an exercise price of $11.70; transaction date 08/07/2025.

What is the vesting schedule for the options reported by SEPN (Form 4)?

The options vest in 1/48th of the shares each month on monthly anniversaries beginning August 1, 2025, subject to continuous service.

When do the options expire and what ownership form was reported?

The option lists an expiration date of 08/06/2035, and the filing reports direct beneficial ownership of 30,000 options.

Who signed the Form 4 and when was it filed?

The Form 4 is signed by Ran Xiao, Attorney-in-Fact on 08/11/2025; the reported transaction date is 08/07/2025.

What is the reporting person's role at Septerna (SEPN)?

The reporting person is identified as Chief People Officer and the form indicates it was filed by one reporting person.
Septerna, Inc.

NASDAQ:SEPN

SEPN Rankings

SEPN Latest News

SEPN Latest SEC Filings

SEPN Stock Data

523.56M
43.38M
2.64%
105.6%
8.4%
Biotechnology
Pharmaceutical Preparations
Link
United States
SOUTH SAN FRANCISCO